Amber Kuykendall, an inspector with the Veterinary Medical Board, inspected an emergency veterinary hospital on April 14, 2025, and issued a report listing multiple corrections the facility must submit within 30 days.

Kuykendall told staff she had marked several items as compliant — including sterilization procedures, anesthesia machines and monitoring, surgical pack indicators, laboratory services using IDEX, and the facility’s DEA registration — but also recorded a number of deficiencies during the on‑site review. "Please discontinue use of Enroflox 100 and submit verification," she said while photographing the product for the inspection record.

The inspector identified the following deficiencies in her generated report: Enroflox 100 (listed as not approved for small‑animal use) left on pharmacy shelves; premade saline flush syringes and multi‑use fluid bags used for flush preparation that must be discontinued; a dental x‑ray unit with no visible service date and described as "has not been serviced in the last year"; unsecured Telazol vials and a lockbox placed in a refrigerator in a way the inspector said could allow easy removal; and controlled‑drug recordkeeping issues including at least one expired controlled drug (buprenorphine) found in the Cubex dispensing unit and multiple vials missing required open/use‑by dates.

Kuykendall photographed each deficiency and added them to the inspection entry in her inspection application. She marked the drug security controls and the specific drug/biologics items as noncompliant in the report and set a corrections due date 30 days out. "The corrections are due on 04/14/2025," she said while generating and reviewing the report with facility staff.

On compliance items the inspector recorded as satisfactory, she said the facility had required postings for employees and Title 17 references near the x‑ray equipment, functioning dosimeters kept in date and away from x‑ray exposure, properly labeled and double‑wrapped surgical packs with indicators, endotracheal tubes used new for each patient, an active scavenging system for anesthesia, and contracted sharps pickup by Stericycle. She also confirmed the facility’s CURES reporting process and that the Cubex system reported controlled‑drug dispensing automatically to CURES; she noted the facility’s managing licensee (MGL) and DEA registration appeared in order.

During the inspection Kuykendall reviewed sterilization indicators (steam and gas sterilizers), anesthesia machine service dates (one entry noted as due in February), x‑ray calibration/service (a calibration record from March 2025 was recorded for one unit), and laboratory outsourcing (IDEX). She told staff she would email the final inspection report and that the facility would have 30 days to upload verification of corrections. The inspector obtained an on‑site signature on the generated inspection report before leaving.

The report records and photographic evidence will be used by the Veterinary Medical Board to verify that the listed corrections — removal or proper labeling of Enroflox 100, discontinuation of premade flush syringes and multi‑use fluid bags for flush prep, proof of dental x‑ray servicing, secure storage of Telazol and documentation of open/use‑by dates on controlled vials, and replacement of expired controlled drugs — have been completed by the April 14, 2025 deadline.

Kuykendall provided office contact information and said staff could submit questions or documentation by email after the inspection. The facility manager signed the report in the inspector’s presence and the inspector said she would follow up by email with a link for uploading corrective documentation.